Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Study Shows Rheumatoid Arthritis Linked to Atrial Fibrillation

Sue Pondrom  |  August 16, 2011

The researchers had suspected that atrial fibrillation might be linked to connective tissue disease because conditions such as RA cause inflammation. To validate their hypothesis, they used data from the 2008 Nationwide Inpatient Sample, which contains discharge data from about 1,000 hospitals in 40 states. They looked at discharge diagnosis of RA, systemic lupus erythematosus (SLE), and atrial fibrillation, and compared 86,497 patients with primary atrial fibrillation to 100,000 randomly selected controls. The researchers found that 2.73% of patients with RA were found to have atrial fibrillation, compared with 1.7% for those without RA. They did not find as significant an association between SLE and atrial fibrillation.

According to Dr. Pisetsky, a key limitation of the study was that it looked only at hospitalized people, and “there may be more A fib in people not in the hospital.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Sue Pondrom is a medical journalist based in San Diego.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

 

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Clinical researchRheumatoid arthritis

Related Articles

    “The Pisetsky Effect”* Helps Mold The Rheumatologist into a Vibrant Publication

    December 12, 2011

    Colleagues and contributors share thoughts as the first editor’s tenure comes to a close

    Rheum After 5: Dr. David Pisetsky, Storyteller

    April 15, 2022

    David S. Pisetsky, MD, PhD, often tells people that science involves reading and writing as much as conducting experiments. No matter what discoveries are made in the lab, if they can’t be communicated well or put into context, he asks, how can they be used to advance the field and benefit patients? The recipient of…

    A 52-Year-Old Lupus Paper Remains Important Today

    December 14, 2020

    Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythema­tosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…

    Year in Review: Rheumatic Disease Research in 2019

    November 20, 2019

    ATLANTA—Encouraging data on interleukin (IL) 23/IL-17 pathway drugs in psoriatic arthritis (PsA), JAK inhibitors in rheumatoid arthritis (RA) treatment and new evidence on physical activity and bone health in women were among the highlights of the 2019 ACR/ARP Annual Meeting’s Clinical Year in Review. Susan Manzi, MD, MPH, director of the Lupus Center for Excellence…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences